Jean Sachs, CEO of Living Beyond Breast Cancer explains what biomarker testing is and why it plays a crucial role in breast cancer treatment. Plus, Aliya Omer with AstraZeneca discusses recent ...

An expert discussed the importance of patients learning about their specific type of breast cancer to understand potential treatment options.

BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection Vancouver, British Columbia--( - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), ...

Various factors, including age, obesity, alcohol consumption, family history and genetic mutations can increase the risk of ...

Patients with a high MeCo score had a longer event-free survival benefit when anti-fibrotic therapy Ofev was added to ...

The bill stalled last year. “Biomarker testing has had some really incredible results when it comes to specifically breast ...

DeepHRD predicted homologous recombination deficiency with greater accuracy than FDA-approved standard molecular tests.

Breast cancer is the most common cancer in women and the second most common cancer overall, impacting 2.1mn women each year.

ESR1 Mutated Metastatic Breast Cancer Diagnostics MarketThe global ESR1 mutated metastatic breast cancer diagnostics market ...

The bill stalled last year. “Biomarker testing has had some really incredible results when it comes to specifically breast cancer,” García said. “There are so many types of breast cancer ...